
Cutrax TZ 250mg/31.25mg Injection
Marketer
Cuber Lifesciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cutrax TZ 250mg/31.25mg Injection
Combiflox TZ 250mg/31.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed regimen is crucial, completing the entire course regardless of symptom improvement. Premature cessation can compromise efficacy. Typical mild side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, itching, edema, respiratory distress). Disclose all current medications to your doctor before commencing treatment, including those for pre-existing conditions. Pregnant or lactating individuals require prior physician approval. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing somnolence or dizziness. Adequate rest, nutritious food, and ample hydration are recommended for optimal recovery. Your physician may order lab tests to monitor the medicine's effects.
Primary Ingredients of Cutrax TZ 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Cutrax TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cutrax TZ 250mg/31.25mg Injection:
Administering this medication will be done by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cutrax TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cutrax TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cutrax TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam (Cutrax TZ 250mg/31.25mg Injection) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concomitant use of Cutrax TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Cutrax TZ 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administration of Cutrax TZ 250mg/31.25mg Injection necessitates prudence while breastfeeding. Lactation should be temporarily discontinued throughout maternal treatment and until complete drug clearance from the maternal system.
DrivingUNSAFE
Administering Cutrax TZ 250mg/31.25mg Injection can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cutrax TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication, Cutrax TZ 250mg/31.25mg, requires careful administration in individuals with advanced hepatic impairment. Dosage modification might be necessary; physician consultation is advised. Altering the Cutrax TZ 250mg/31.25mg Injection dose isn't suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cutrax TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Cutrax TZ 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Cutrax TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
